Liang Li
Managing Partner at LLX Solutions LLC
Waltham, Massachusetts, United States
Summary
👤
Senior🎓
Top SchoolLiang Li is an experienced biostatistician and managing partner with over 20 years in clinical and preclinical drug development, and more than 16 years leading statistical programs within biotech, pharma, and medical device companies. He has designed and analyzed Phase I–IV trials and registries, led statistical submissions for U.S. and international regulatory agencies, and supported FDA Advisory Committee reviews. Liang combines deep familiarity with FDA/EMEA/PMDA/ICH guidance with hands-on management of in-house and CRO-led projects, collaborating closely with medical and statistical experts to shape study design and publications. Based in Waltham, MA, he brings both technical rigor from a PhD in Pharmacology and an MS in Statistics and a pragmatic consulting mindset that helps teams navigate complex regulatory pathways. A detail-oriented strategist, he’s known for turning regulatory complexity into clear, auditable statistical plans that advance program milestones.
9 years of coding experience
6 years of employment as a software developer
The University of UtahBachelor of Medicine Pharmacy, Bachelor of Medicine Pharmacy at Beijing University of Chinese MedicinePhD Pharmacology, PhD Pharmacology at University of Helsinki
Github Skills (11)
webpack5
axios5
vue5
tooling5
vuex4
react3
react-admin3
vue-router3
redux3
element-ui2
antd1
Programming languages (2)
Github contributions (5)
llx123/react-admin-authority
Feb 2019 - Apr 2020
react后台管理系统解决方案
Contributions:42 commits, 24 pushes, 1 branch in 1 year 2 months
reactreact-adminant-designaxiosantd
llx123/vue-admin-authority
Oct 2018 - Apr 2020
vue后台管理系统解决方案
Contributions:93 commits, 52 pushes, 1 branch in 1 year 5 months
vue-routerelement-uiaxiosvuevuex
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.